MCP Tips for better browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M400143-MCP200 on December 10, 2004.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M400143-MCP200v1
4/1/84    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schilling, B.
Right arrow Articles by Gibson, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schilling, B.
Right arrow Articles by Gibson, B. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:84-96, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Rapid Purification and Mass Spectrometric Characterization of Mitochondrial NADH Dehydrogenase (Complex I) from Rodent Brain and a Dopaminergic Neuronal Cell Line*,S

Birgit Schilling{ddagger},§, Srinivas Bharath M.M.{ddagger},§, Richard H. Row{ddagger}, James Murray, Michael P. Cusack{ddagger}, Roderick A. Capaldi, Curt R. Freed||, Kedar N. Prasad**, Julie K. Andersen{ddagger} and Bradford W. Gibson{ddagger},{ddagger}{ddagger},§§

From the {ddagger} Buck Institute for Age Research, Novato, CA 94945; Department of Molecular Biology, University of Oregon, Eugene, OR 97403; || Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Neuroscience Program, University of Colorado Health Sciences Center, Denver, CO 80262; ** Center for Vitamins and Cancer Research, Department of Radiology, University of Colorado Health Sciences Center, Denver, CO 80262; {ddagger}{ddagger} Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143

Oxidative stress and mitochondrial dysfunction signify important biochemical events associated with the loss of dopaminergic neurons in Parkinson’s disease (PD). Studies using in vitro and in vivo PD models or tissues from diseased patients have demonstrated a selective inhibition of mitochondrial NADH dehydrogenase (Complex I of the OXPHOS electron transport chain) that affects normal mitochondrial physiology leading to neuronal death. In an earlier study, we demonstrated that oxidative stress due to glutathione depletion in dopaminergic cells, a hallmark of PD, leads to Complex I inhibition via cysteine thiol oxidation (Jha et al. (2000) J. Biol. Chem. 275, 26096–26101). Complex I is a ~980-kDa multimeric enzyme spanning the inner mitochondrial membrane comprising at least 45 protein subunits. As a prerequisite to investigating modifications to Complex I using a rodent disease model for PD, we developed two independent rapid and mild isolation procedures based on sucrose gradient fractionation and immunoprecipitation to isolate Complex I from mouse brain and a cultured rat mesencephalic dopaminergic neuronal cell line. Both protocols are capable of purifying Complex I from small amounts of rodent tissue and cell cultures. Blue Native gel electrophoresis, one-dimensional and two-dimensional SDS-PAGE were employed to assess the purity and composition of isolated Complex I followed by extensive mass spectrometric characterization. Altogether, 41 of 45 rodent Complex I subunits achieved MS/MS sequence coverage. To our knowledge, this study provides the first detailed mass spectrometric analysis of neuronal Complex I proteins and provides a means to investigate the role of cysteine oxidation and other posttranslational modifications in pathologies associated with mitochondrial dysfunction.

§§ To whom correspondence should be addressed: Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945. Tel.: 415-209-2032; Fax: 415-209-2231; E-mail: bgibson{at}buckinstitute.org


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
S. J. Chinta, M. J. Kumar, M. Hsu, S. Rajagopalan, D. Kaur, A. Rane, D. G. Nicholls, J. Choi, and J. K. Andersen
Inducible Alterations of Glutathione Levels in Adult Dopaminergic Midbrain Neurons Result in Nigrostriatal Degeneration
J. Neurosci., December 19, 2007; 27(51): 13997 - 14006.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
G. Pocsfalvi, M. Cuccurullo, G. Schlosser, S. Scacco, S. Papa, and A. Malorni
Phosphorylation of B14.5a Subunit from Bovine Heart Complex I Identified by Titanium Dioxide Selective Enrichment and Shotgun Proteomics
Mol. Cell. Proteomics, February 1, 2007; 6(2): 231 - 237.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Schilling, J. Gafni, C. Torcassi, X. Cong, R. H. Row, M. A. LaFevre-Bernt, M. P. Cusack, T. Ratovitski, R. Hirschhorn, C. A. Ross, et al.
Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry: MODULATION OF CLEAVAGE AND TOXICITY
J. Biol. Chem., August 18, 2006; 281(33): 23686 - 23697.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.